APA (7th ed.) Citation

JA, J., MS, K., BS, G., ME, K., DD, L., JJ, L., . . . Jr, B. G. (2015). Phase II study of gefitinib in patients with advanced salivary gland cancers. Head & neck, 37(5), 644. https://doi.org/10.1002/hed.23647

Chicago Style (17th ed.) Citation

JA, Jakob, Kies MS, Glisson BS, Kupferman ME, Liu DD, Lee JJ, El-Naggar AK, Gonzalez-Angulo AM, and Blumenschein GR Jr. "Phase II Study of Gefitinib in Patients with Advanced Salivary Gland Cancers." Head & Neck 37, no. 5 (2015): 644. https://doi.org/10.1002/hed.23647.

MLA (9th ed.) Citation

JA, Jakob, et al. "Phase II Study of Gefitinib in Patients with Advanced Salivary Gland Cancers." Head & Neck, vol. 37, no. 5, 2015, p. 644, https://doi.org/10.1002/hed.23647.